BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 34534465)

  • 1. Proteogenomic characterization of pancreatic ductal adenocarcinoma.
    Cao L; Huang C; Cui Zhou D; Hu Y; Lih TM; Savage SR; Krug K; Clark DJ; Schnaubelt M; Chen L; da Veiga Leprevost F; Eguez RV; Yang W; Pan J; Wen B; Dou Y; Jiang W; Liao Y; Shi Z; Terekhanova NV; Cao S; Lu RJ; Li Y; Liu R; Zhu H; Ronning P; Wu Y; Wyczalkowski MA; Easwaran H; Danilova L; Mer AS; Yoo S; Wang JM; Liu W; Haibe-Kains B; Thiagarajan M; Jewell SD; Hostetter G; Newton CJ; Li QK; Roehrl MH; Fenyö D; Wang P; Nesvizhskii AI; Mani DR; Omenn GS; Boja ES; Mesri M; Robles AI; Rodriguez H; Bathe OF; Chan DW; Hruban RH; Ding L; Zhang B; Zhang H;
    Cell; 2021 Sep; 184(19):5031-5052.e26. PubMed ID: 34534465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
    Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
    J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
    ;
    Cancer Cell; 2017 Aug; 32(2):185-203.e13. PubMed ID: 28810144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
    Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
    Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
    Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
    J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
    BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
    Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
    Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma.
    Yang J; Lin P; Yang M; Liu W; Fu X; Liu D; Tao L; Huo Y; Zhang J; Hua R; Zhang Z; Li Y; Wang L; Xue J; Li H; Sun Y
    Genome Biol; 2021 Jan; 22(1):4. PubMed ID: 33397441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
    Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
    Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
    Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
    J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
    Clark DJ; Dhanasekaran SM; Petralia F; Pan J; Song X; Hu Y; da Veiga Leprevost F; Reva B; Lih TM; Chang HY; Ma W; Huang C; Ricketts CJ; Chen L; Krek A; Li Y; Rykunov D; Li QK; Chen LS; Ozbek U; Vasaikar S; Wu Y; Yoo S; Chowdhury S; Wyczalkowski MA; Ji J; Schnaubelt M; Kong A; Sethuraman S; Avtonomov DM; Ao M; Colaprico A; Cao S; Cho KC; Kalayci S; Ma S; Liu W; Ruggles K; Calinawan A; Gümüş ZH; Geiszler D; Kawaler E; Teo GC; Wen B; Zhang Y; Keegan S; Li K; Chen F; Edwards N; Pierorazio PM; Chen XS; Pavlovich CP; Hakimi AA; Brominski G; Hsieh JJ; Antczak A; Omelchenko T; Lubinski J; Wiznerowicz M; Linehan WM; Kinsinger CR; Thiagarajan M; Boja ES; Mesri M; Hiltke T; Robles AI; Rodriguez H; Qian J; Fenyö D; Zhang B; Ding L; Schadt E; Chinnaiyan AM; Zhang Z; Omenn GS; Cieslik M; Chan DW; Nesvizhskii AI; Wang P; Zhang H;
    Cell; 2019 Oct; 179(4):964-983.e31. PubMed ID: 31675502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.
    Nones K; Waddell N; Song S; Patch AM; Miller D; Johns A; Wu J; Kassahn KS; Wood D; Bailey P; Fink L; Manning S; Christ AN; Nourse C; Kazakoff S; Taylor D; Leonard C; Chang DK; Jones MD; Thomas M; Watson C; Pinese M; Cowley M; Rooman I; Pajic M; ; Butturini G; Malpaga A; Corbo V; Crippa S; Falconi M; Zamboni G; Castelli P; Lawlor RT; Gill AJ; Scarpa A; Pearson JV; Biankin AV; Grimmond SM
    Int J Cancer; 2014 Sep; 135(5):1110-8. PubMed ID: 24500968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes.
    Hyeon DY; Nam D; Han Y; Kim DK; Kim G; Kim D; Bae J; Back S; Mun DG; Madar IH; Lee H; Kim SJ; Kim H; Hyun S; Kim CR; Choi SA; Kim YR; Jeong J; Jeon S; Choo YW; Lee KB; Kwon W; Choi S; Goo T; Park T; Suh YA; Kim H; Ku JL; Kim MS; Paek E; Park D; Jung K; Baek SH; Jang JY; Hwang D; Lee SW
    Nat Cancer; 2023 Feb; 4(2):290-307. PubMed ID: 36550235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
    Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
    Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma.
    Chen DT; Davis-Yadley AH; Huang PY; Husain K; Centeno BA; Permuth-Wey J; Pimiento JM; Malafa M
    PLoS One; 2015; 10(8):e0133562. PubMed ID: 26247463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
    You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
    Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic cancer.
    Ren X; Zhou C; Lu Y; Ma F; Fan Y; Wang C
    Bioengineered; 2021 Dec; 12(1):5056-5068. PubMed ID: 34474642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.